Literature DB >> 8299648

Polyclonal 111In-IgG, 125I-LDL and 125I-endothelin-1 accumulation in experimental arterial wall injury.

L Prat1, G Torres, I Carrió, M Roca, V Riambau, L Berná, M Estorch, I Ferrer, C García.   

Abstract

To test iodine-125 labelled low-density lipoprotein (125I-LDL), polyclonal indium-111 labelled immunoglobulin G (111In-IgG) and iodine-125 labelled endothelin-1 uptake in metabolically active atheromatous plaques after arterial wall injury, we performed balloon de-endothelialization of carotid arteries or abdominal aortas in 24 New Zealand male rabbits which were fed with a normal diet (n = 14) or a hypercholesterolaemic diet (n = 10) after surgery. Six weeks later the animals were injected with 200 microCi of 125I-LDL and/or with 100 microCi of 111In-IgG or with 9 microCi of 125I-endothelin-1. Forty-eight hours later the animals were sacrificed. Carotid arteries and aortas were removed, counted and fixed for autoradiography and light microscopy examination. Contralateral carotid arteries and thoracic aortas served as controls. Significant 111In-IgG uptake was observed in the injured arteries at autoradiography, with localization mainly in the healing edges, and at well counting. The percentage of the injected dose per gram (%D.inj/g) was 0.0188 +/- 0.06 versus 0.0059 +/- 0.003 in controls (P < 0.05). There was no difference in 111In-IgG uptake between arteries with injury alone and those with active atheroma formation at the site of the injury. Significant 125I-LDL uptake was observed only when lipid deposition was present at light microscopy (%D.inj/g of 0.0024 +/- 0.0005 vs. 0.0010 +/- 0.0003 in controls, P < 0.05). 125I-endothelin-1 accumulation was observed in four of five injured aortas both at autoradiography, with diffuse localization, and at well counting (%D.inj/g of 0.0012 +/- 0.0004 in the abdominal aortas vs 0.0008 +/- 0.0003 in the thoracic aortas).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8299648     DOI: 10.1007/BF00171011

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  19 in total

Review 1.  Nuclear medicine and atherosclerosis.

Authors:  H Sinzinger; I Virgolini
Journal:  Eur J Nucl Med       Date:  1990

2.  Accumulation of immunoglobulin G at focal sites of inflammation.

Authors:  M Juweid; H W Strauss; H Yaoita; R H Rubin; A J Fischman
Journal:  Eur J Nucl Med       Date:  1992

3.  Noninvasive imaging of 99mtechnetium-labeled low density lipoprotein uptake by tendon xanthomas in hypercholesterolemic patients.

Authors:  H N Ginsberg; S J Goldsmith; S Vallabhajosula
Journal:  Arteriosclerosis       Date:  1990 Mar-Apr

Review 4.  99mTc-low density lipoprotein: intracellularly trapped radiotracer for noninvasive imaging of low density lipoprotein metabolism in vivo.

Authors:  S Vallabhajosula; S J Goldsmith
Journal:  Semin Nucl Med       Date:  1990-01       Impact factor: 4.446

5.  Iodination of proteins, glycoproteins, and peptides using a solid-phase oxidizing agent, 1,3,4,6-tetrachloro-3 alpha,6 alpha-diphenyl glycoluril (Iodogen).

Authors:  P R Salacinski; C McLean; J E Sykes; V V Clement-Jones; P J Lowry
Journal:  Anal Biochem       Date:  1981-10       Impact factor: 3.365

6.  Radionuclide imaging of experimental atherosclerosis with nonspecific polyclonal immunoglobulin G.

Authors:  A J Fischman; R H Rubin; B A Khaw; P B Kramer; R Wilkinson; M Ahmad; M Needelman; E Locke; N D Nossiff; H W Strauss
Journal:  J Nucl Med       Date:  1989-06       Impact factor: 10.057

7.  External imaging of human atherosclerosis.

Authors:  R S Lees; A M Lees; H W Strauss
Journal:  J Nucl Med       Date:  1983-02       Impact factor: 10.057

8.  Factors influencing DTPA conjugation with antibodies by cyclic DTPA anhydride.

Authors:  C H Paik; M A Ebbert; P R Murphy; C R Lassman; R C Reba; W C Eckelman; K Y Pak; J Powe; Z Steplewski; H Koprowski
Journal:  J Nucl Med       Date:  1983-12       Impact factor: 10.057

9.  Indium-111-labeled LDL: a potential agent for imaging atherosclerotic disease and lipoprotein biodistribution.

Authors:  J M Rosen; S P Butler; G E Meinken; T S Wang; R Ramakrishnan; S C Srivastava; P O Alderson; H N Ginsberg
Journal:  J Nucl Med       Date:  1990-03       Impact factor: 10.057

10.  Low density lipoprotein metabolism by human macrophages activated with low density lipoprotein immune complexes. A possible mechanism of foam cell formation.

Authors:  R L Griffith; G T Virella; H C Stevenson; M F Lopes-Virella
Journal:  J Exp Med       Date:  1988-09-01       Impact factor: 14.307

View more
  3 in total

1.  Noninvasive localization of human atherosclerotic lesions with indium 111-labeled monoclonal Z2D3 antibody specific for proliferating smooth muscle cells.

Authors:  I Carrió; P L Pieri; J Narula; L Prat; P Riva; L Pedrini; E Pretolani; G Caruso; G Sarti; M Estorch; L Berná; V Riambau; X Matías-Guiu; C Pak; C Ditlow; F Chen; B A Khaw
Journal:  J Nucl Cardiol       Date:  1998 Nov-Dec       Impact factor: 5.952

Review 2.  What is the current status of quantification and nuclear medicine in cardiology?

Authors:  G Hör
Journal:  Eur J Nucl Med       Date:  1996-07

3.  99mTc-interleukin-2 scintigraphy for the in vivo imaging of vulnerable atherosclerotic plaques.

Authors:  Alessio Annovazzi; Elena Bonanno; Marcello Arca; Calogero D'Alessandria; Antonella Marcoccia; Luigi G Spagnoli; Francesco Violi; Francesco Scopinaro; Giorgio De Toma; Alberto Signore
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-10-12       Impact factor: 9.236

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.